Meda AB
Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. Meda imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are currently sold in more than 150 countries.[self-published source]
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Butisol | Butabarbital | 1982-01-01 | ||
| Reglan | Metoclopramide | 2005-06-10 | 2029-2030 | |
| Rowasa | Mesalamine | 1990-12-18 | 2027-2030 | |
| Soma | Aspirin, Carisoprodol, Codeine | 1983-07-11 | 2023-2033 | |
| Sonata | Zaleplon | 1999-03-12 | ||
| Thyro-block | Potassium iodide | 1982-01-01 | ||
| Zerene | Zaleplon | 1999-03-12 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use